Chenguang Biotech Group (300138.SZ): The net income in the first half of the year was 99.8346 million yuan, a year-on-year decrease of 66.57%.

Gelonghui Finance · Aug 26 04:28

Chenguang Biotech Group (300138.SZ) released its semi-annual report for 2024, with a total operating income of 3.491 billion yuan, a year-on-year decrease of 4.85%; net income attributable to shareholders of the listed company was 99.8346 million yuan, a year-on-year decrease of 66.57%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 80.0377 million yuan, a year-on-year decrease of 66.06%; basic earnings per share was 0.19 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more

晨光生物(300138.SZ)：上半年净利润9983.46万元，同比下降66.57%

Chenguang Biotech Group (300138.SZ): The net income in the first half of the year was 99.8346 million yuan, a year-on-year decrease of 66.57%.

Risk Disclaimer

Statement